Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease
Authors
Keywords
Inflammatory bowel disease, Biomarker, Trimethylamine-<em class=EmphasisTypeItalic >N</em>-oxide, Microbial-mammalian co-metabolism
Journal
DIGESTIVE DISEASES AND SCIENCES
Volume 60, Issue 12, Pages 3620-3630
Publisher
Springer Nature
Online
2015-07-09
DOI
10.1007/s10620-015-3797-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study
- (2014) Carolyn A Miller et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry
- (2014) Zeneng Wang et al. ANALYTICAL BIOCHEMISTRY
- The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
- (2014) Aleksandar D. Kostic et al. GASTROENTEROLOGY
- Meta-analysis
- (2014) Jin-Feng Lin et al. INFLAMMATORY BOWEL DISEASES
- Adeno-associated Virus–mediated Delivery of a Recombinant Single-chain Antibody Against Misfolded Superoxide Dismutase for Treatment of Amyotrophic Lateral Sclerosis
- (2014) Priyanka Patel et al. MOLECULAR THERAPY
- Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases
- (2014) Tomasz Dawiskiba WORLD JOURNAL OF GASTROENTEROLOGY
- Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity
- (2013) J. W. Berrill et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Gut microbiota metabolism of l-carnitine and cardiovascular risk
- (2013) John R. Ussher et al. ATHEROSCLEROSIS
- Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation
- (2013) Brian J. Bennett et al. Cell Metabolism
- Diet rapidly and reproducibly alters the human gut microbiome
- (2013) Lawrence A. David et al. NATURE
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis
- (2013) Robert A Koeth et al. NATURE MEDICINE
- Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
- (2013) W.H. Wilson Tang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme
- (2012) S. Craciun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Biomarkers in inflammatory bowel disease: current practices and recent advances
- (2012) Heba N. Iskandar et al. Translational Research
- Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
- (2012) Xochitl C Morgan et al. GENOME BIOLOGY
- Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
- (2011) Natalie A. Molodecky et al. GASTROENTEROLOGY
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- (2011) R. M. Gadaleta et al. GUT
- Serological Antibodies in Inflammatory Bowel Disease: A Systematic Review
- (2011) Lani Prideaux et al. INFLAMMATORY BOWEL DISEASES
- The Footprints of Gut Microbial–Mammalian Co-Metabolism
- (2011) Xiaojiao Zheng et al. JOURNAL OF PROTEOME RESEARCH
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
- (2011) Zeneng Wang et al. NATURE
- Genetics and pathogenesis of inflammatory bowel disease
- (2011) Bernard Khor et al. NATURE
- Enterotypes of the human gut microbiome
- (2011) Manimozhiyan Arumugam et al. NATURE
- Farnesoid X Receptor (FXR) Activation and FXR Genetic Variation in Inflammatory Bowel Disease
- (2011) Rian M. Nijmeijer et al. PLoS One
- The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
- (2011) Sabrina Cipriani et al. PLoS One
- Bacterial flavin-containing monooxygenase is trimethylamine monooxygenase
- (2011) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
- (2011) G. D. Wu et al. SCIENCE
- A Pyrosequencing Study in Twins Shows That Gastrointestinal Microbial Profiles Vary With Inflammatory Bowel Disease Phenotypes
- (2010) Ben P. Willing et al. GASTROENTEROLOGY
- Dysbiosis of fecal microbiota in Crohnʼs disease patients as revealed by a custom phylogenetic microarray
- (2010) Seungha Kang et al. INFLAMMATORY BOWEL DISEASES
- Microbiota in Pediatric Inflammatory Bowel Disease
- (2010) Andreas Schwiertz et al. JOURNAL OF PEDIATRICS
- Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation
- (2008) Francesco Raimondi et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
- (2008) Erik von Elm et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease
- (2007) Hiromasa Takaishi et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation